Outset Medical, Inc.
OM
$4.62
-$0.07-1.49%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 117.59M | 119.48M | 120.07M | 119.30M | 115.27M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 117.59M | 119.48M | 120.07M | 119.30M | 115.27M |
| Cost of Revenue | 69.80M | 72.72M | 74.75M | 75.76M | 73.81M |
| Gross Profit | 47.78M | 46.75M | 45.32M | 43.55M | 41.46M |
| SG&A Expenses | 93.67M | 92.23M | 91.63M | 95.12M | 102.49M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 184.81M | 186.18M | 189.60M | 196.86M | 206.73M |
| Operating Income | -67.23M | -66.71M | -69.53M | -77.56M | -91.46M |
| Income Before Tax | -74.03M | -80.94M | -87.18M | -97.51M | -113.37M |
| Income Tax Expenses | 820.00K | 718.00K | 619.00K | 397.00K | 444.00K |
| Earnings from Continuing Operations | -74.85 | -81.65 | -87.80 | -97.90 | -113.82 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -74.85M | -81.65M | -87.80M | -97.90M | -113.82M |
| EBIT | -67.23M | -66.71M | -69.53M | -77.56M | -91.46M |
| EBITDA | -63.38M | -62.37M | -64.67M | -72.31M | -85.89M |
| EPS Basic | -4.18 | -6.81 | -13.00 | -20.02 | -28.94 |
| Normalized Basic EPS | -2.58 | -3.54 | -7.17 | -11.53 | -17.08 |
| EPS Diluted | -4.18 | -6.81 | -13.00 | -20.02 | -28.94 |
| Normalized Diluted EPS | -2.58 | -3.54 | -7.17 | -11.53 | -17.08 |
| Average Basic Shares Outstanding | 71.72M | 60.38M | 46.08M | 31.78M | 17.50M |
| Average Diluted Shares Outstanding | 71.72M | 60.38M | 46.08M | 31.78M | 17.50M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |